Obesity medication prescriptions reached 1.5 million, driven by GLP-1 agents semaglutide and tirzepatide, as public interest ...

Here is some info from Ohio State – improving lives through excellence in research, education and patient care.

Researchers at the, Riverside, backed by a substantial NIH grant, are pioneering a study on the unique immune responses to ...